Garden Stage Ltd

This Current Report on Form 6-K is filed for the sole purpose of correcting inadvertent errors on the cover pages of relevant prospectus supplements.

Paragraph 4 on the front cover page of the Prospectus Supplement dated April 9, 2025, to the Prospectus dated March 10, 2025 is hereby amended and restated in its entirety by the following paragraph:

Pursuant to General Instruction I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than one-third of the aggregate market value of our Ordinary Shares in any 12-month period so long as the aggregate market value of our voting and non-voting common equity held by non-affiliates remains below $75,000,000. During the 12 calendar months prior to and including the date of this prospectus supplement, we sold $1,489,999.50 worth of securities pursuant to General Instruction I.B.5 of Form F-3.

Paragraph 4 on the front cover page of the Prospectus Supplement dated June 18, 2025, to the Prospectus dated March 10, 2025 is hereby amended and restated in its entirety by the following paragraph:

Pursuant to General Instruction I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than one-third of the aggregate market value of our Ordinary Shares in any 12-month period so long as the aggregate market value of our voting and non-voting common equity held by non-affiliates remains below $75,000,000. During the 12 calendar months prior to and including the date of this prospectus supplement, we sold $2,480,000 worth of securities pursuant to General Instruction I.B.5 of Form F-3.

Paragraph 6 on the front cover page of the Prospectus Supplement dated July 25, 2025, to the Prospectus dated March 10, 2025 is hereby amended and restated in its entirety by the following paragraph:

Pursuant to General Instruction I.B.5. of Form F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than one-third of the aggregate market value of our Ordinary Shares in any 12-month period so long as the aggregate market value of our voting and non-voting common equity held by non-affiliates remains below $75,000,000. During the 12 calendar months prior to and including the date of this prospectus supplement, we sold $6,140,000 worth of securities pursuant to General Instruction I.B.5 of Form F-3.

Paragraphs 3 on the front cover page of the Prospectus Supplement dated September 17, 2025 to the Prospectus dated March 10, 2025 is hereby amended and restated in its entirety by the following paragraph and paragraph 4 on such front cover page is hereby deleted in its entirety:

The aggregate market value of our outstanding Ordinary Shares held by non-affiliates or public float, as of the date of September 15, 2025, was approximately $112,089,026.85, which was calculated based on 64,393,265 Ordinary Shares held by non-affiliates and the per share price of $1.73, which was the closing price of our Ordinary Shares on Nasdaq on July 17, 2025.

Except as specifically amended and restated herein, all other information in the relevant prospectus supplements remain unchanged.